Author: Cancer Research Technology (CRT)

Cancer Research Technology has signed a further deal with Merck to discover new cancer drugs targeting the Hippo pathway.

Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute.

Cancer Research Technology, Tusk Therapeutics and UCL have signed an agreement to research, develop and commercialise an antibody-based therapeutic.

Cancer Research Technology and Varleigh Dx have jointly launched a new test as an aid in the diagnosis of patients with pancreatic cancer.

Ximbio, a non-profit online one-stop-shop for the global life science community to share research resources, has opened its first North American headquarters.

The Cancer Research Technology (CRT) Pioneer Fund announced an investment to develop a promising new class of drugs for blood cancer.

Cancer Research UK and Cancer Research Technology (CRT) have signed an agreement with TYG oncology Ltd (TYG) to take its new cancer vaccine into clinical trials

Cancer Research Technology (CRT) has today received a success payment from GlaxoSmithKline resulting from its research collaboration.

Syncona LLP and Cancer Research Technology (CRT) announce the formation of Achilles Therapeutics Ltd today.

Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma.